Wound Healing and Skin Repair

SECTION 1

Historical Context & Motivation

Humans have attempted to understand and facilitate wound healing since the earliest civilizations, recognizing that the difference between a wound that heals cleanly and one that festers can be the difference between life and death. Ancient Egyptian papyri, Greco-Roman surgical treatises, and medieval herbal compendiums all document efforts to accelerate tissue repair, yet a mechanistic understanding of the process did not emerge until the advent of microscopy and modern cell biology. The study of wound healing sits at the intersection of immunology, cell biology, and tissue engineering, and it continues to drive innovations ranging from advanced wound dressings to regenerative medicine. Understanding the phases and cellular players involved in skin repair is therefore foundational for students of anatomy and physiology—it integrates concepts of inflammation, extracellular matrix remodeling, and epithelial biology into a single, clinically relevant narrative.

c. 1600 BCE

Edwin Smith Papyrus

One of the earliest surgical documents describes wound examination, classification by prognosis, and treatments including honey and grease—substances now recognized for their antimicrobial and moisture-retentive properties.

1858

Virchow's Cellular Pathology

Rudolf Virchow established that disease and repair processes originate from cells, not from humoral imbalances, shifting wound-healing research toward cellular mechanisms such as inflammation and proliferation.

1962

Winter's Moist Wound Healing

George Winter demonstrated that wounds kept in a moist environment re-epithelialize approximately twice as fast as those exposed to air, revolutionizing clinical wound care and dressing design.

1986

Growth Factor Discovery

Rita Levi-Montalcini and Stanley Cohen received the Nobel Prize for discovering nerve growth factor and epidermal growth factor (EGF), molecules now known to orchestrate key steps in wound repair.

2000s–Present

Regenerative Medicine Era

Advances in stem cell biology, bioengineered skin substitutes, and platelet-rich plasma therapies are enabling approaches that aim to regenerate tissue rather than simply repair it with scar.

Despite millennia of observation, a central question persists: why do adult human wounds typically heal by fibrotic scar formation rather than true regeneration, as seen in fetal skin and in organisms like salamanders? This question motivates ongoing research and frames the fundamental phases of wound healing that we will explore in this lesson—hemostasis, inflammation, proliferation, and remodeling.

SECTION 2

Core Principles of Wound Healing

Wound healing in the skin is conventionally described as a continuum of four overlapping phases, each driven by distinct cell populations, signaling molecules, and extracellular matrix dynamics. Although textbooks present them sequentially, it is important to appreciate that these phases are temporally overlapping and spatially heterogeneous—different regions of a single wound may be in different phases simultaneously. The framework below distills the four cardinal phases and one overarching principle that govern all cutaneous wound repair.

Hemostasis

Within seconds to minutes of injury, platelet aggregation and the coagulation cascade form a fibrin clot that stops bleeding and provides a provisional scaffold for incoming cells.

Inflammation

Neutrophils arrive within hours, followed by macrophages that phagocytose debris, kill bacteria, and release cytokines (e.g., TNF-α, IL-1) that recruit reparative cells to the wound site.

Proliferation

Fibroblasts deposit type III collagen and form granulation tissue, keratinocytes migrate and divide to re-epithelialize the surface, and new capillaries sprout via angiogenesis to supply the metabolically active wound bed.

Remodeling (Maturation)

Over weeks to years, type III collagen is replaced by type I collagen, cross-linking increases tensile strength, and the scar matures—ultimately reaching only about 80% of the original skin's strength.

Overlapping Cascade Principle

All four phases are regulated by paracrine signaling among platelets, immune cells, fibroblasts, and keratinocytes. Disruption at any point—such as persistent inflammation in diabetic ulcers—can stall the entire process.

✦ KEY TAKEAWAY

Think of wound healing like a relay race with overlapping handoffs: the hemostasis team (platelets) starts running, then passes the baton to the inflammation team (neutrophils and macrophages), which hands off to the proliferation team (fibroblasts and keratinocytes), and finally the remodeling team (myofibroblasts and matrix metalloproteinases) carries it to the finish. If any runner stumbles or refuses to leave the track, the entire race stalls—just as a wound that remains chronically inflamed cannot progress to productive tissue repair.

SECTION 3

Visual Overview of the Four Phases

The following diagram illustrates the temporal overlap of the four phases of wound healing, plotting each phase's relative intensity against time after injury. Notice how inflammation peaks within the first few days but begins declining as proliferative activity ramps up, and how remodeling persists long after the wound appears clinically closed. This overlapping architecture ensures that each phase provides the molecular signals necessary to initiate the next.

Each colored curve represents the relative activity of a wound-healing phase over time. Hemostasis (red) is the briefest phase, peaking within minutes. Inflammation (orange) peaks over the first few days. Proliferation (green) dominates during weeks 1–3. Remodeling (violet) continues for months to years after injury.

Several features of this temporal architecture deserve emphasis. First, the brevity of hemostasis is remarkable—platelet plug formation and fibrin polymerization achieve provisional closure within minutes, setting the stage for all subsequent events. Second, the inflammatory phase must be self-limiting; prolonged neutrophil activity releases excessive reactive oxygen species and matrix metalloproteinases that degrade nascent repair tissue. Third, note that the remodeling curve never truly returns to baseline in the timeframe shown—this reflects the clinical observation that scar tissue continues to mature for up to two years after initial injury, gradually gaining tensile strength as collagen fibers are reorganized along lines of mechanical stress.

SECTION 4

Cellular & Molecular Mechanisms

Although wound healing is not typically described using mathematical equations in the way a physics course might, quantitative relationships do exist and are increasingly important in wound care research and clinical practice. Understanding the kinetics of wound contraction, the balance between collagen synthesis and degradation, and the rate of epithelial migration provides a more rigorous framework for predicting healing outcomes. Below, we examine key quantitative principles alongside the molecular machinery of each phase.

Hemostasis: The Coagulation Cascade

Injury to a blood vessel exposes subendothelial collagen and von Willebrand factor (vWF), which bind platelet surface glycoproteins (GPIb and GPIa/IIa), triggering platelet adhesion, activation, and aggregation. Activated platelets degranulate, releasing platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β), and thromboxane A₂. Simultaneously, the extrinsic coagulation pathway (triggered by tissue factor exposure) and the intrinsic pathway converge on the common pathway, culminating in thrombin-mediated conversion of fibrinogen to fibrin. Factor XIII cross-links fibrin strands into a stable meshwork that serves as both a hemostatic plug and a provisional matrix for cell migration.

Inflammation: Immune Cell Recruitment

Within hours, neutrophils are recruited via chemotactic gradients (IL-8, complement fragment C5a, leukotriene B₄) and extravasate through post-capillary venules via selectin-mediated rolling, integrin-mediated firm adhesion, and diapedesis. Neutrophils phagocytose bacteria and debris using reactive oxygen species and antimicrobial peptides. By 48–72 hours, neutrophil numbers decline (largely through apoptosis), and monocyte-derived macrophages become the dominant cell type. Macrophages are arguably the master regulators of wound healing: M1-polarized (classically activated) macrophages sustain inflammation and debridement, while M2-polarized (alternatively activated) macrophages release anti-inflammatory cytokines (IL-10, TGF-β) and pro-angiogenic factors (VEGF) that initiate the transition to the proliferative phase.

Proliferation: Re-epithelialization and Granulation

Re-epithelialization involves the migration and mitosis of keratinocytes from wound edges and adnexal structures (hair follicles, sweat glands). Keratinocytes at the wound margin lose their hemidesmosomes, express integrins for fibronectin and fibrin, and begin migrating over the provisional matrix at a rate of approximately 0.5–1.0 mm/day under optimal conditions. Beneath the advancing epithelial sheet, fibroblasts migrate into the wound, proliferate, and secrete extracellular matrix components—predominantly type III collagen, fibronectin, and hyaluronic acid—forming granulation tissue. Concurrently, endothelial cells sprout from existing venules in a process called angiogenesis, driven by VEGF, FGF-2, and low oxygen tension in the wound bed.

WOUND CONTRACTION RATE

ΔA/Δt ≈ −k × P

Where ΔA/Δt = rate of wound area decrease (cm²/day), k = contraction constant (depends on tissue type and wound geometry), and P = wound perimeter (cm). This approximation reflects that contraction occurs at the wound edges, where myofibroblasts generate centripetal force.

Remodeling: Scar Maturation

During remodeling, matrix metalloproteinases (MMPs) degrade the provisional type III collagen, and fibroblasts replace it with thicker, cross-linked type I collagen fibers oriented along lines of tensile stress. The balance between MMP activity and their inhibitors (TIMPs) is critical; excessive MMP activity leads to chronic non-healing wounds, while insufficient MMP activity contributes to hypertrophic scarring and keloids. Wound tensile strength increases rapidly in the first six weeks, reaching approximately 50% of normal skin strength, and continues to increase slowly over 1–2 years, plateauing at roughly 80% of unwounded skin tensile strength.

COLLAGEN TURNOVER EQUILIBRIUM

Net Collagen = Σ(Synthesis by fibroblasts) − Σ(Degradation by MMPs)

In a normally healing wound, synthesis exceeds degradation during the proliferative phase, reaching a dynamic equilibrium during remodeling. In chronic wounds, MMP activity is elevated and TIMP levels are low, shifting the balance toward net degradation.

SECTION 5

Wound Classification & Healing Types

Clinicians classify wound healing into three main types based on the extent of tissue loss and the method of wound closure. These categories have direct implications for healing duration, infection risk, scar formation, and clinical management. Understanding these distinctions is essential for integrating basic science knowledge with clinical reasoning.

Comparison of the three types of wound closure. Primary intention involves clean edges sutured together. Secondary intention relies on granulation tissue to fill a large defect. Tertiary (delayed primary) intention involves intentional delayed closure after initial debridement.

Comparison of wound healing by intention type

Feature	Primary Intention	Secondary Intention	Tertiary Intention
Wound edges	Closely approximated (sutured, stapled, or taped)	Left open; edges widely separated	Initially open; closed after 3–5 days
Granulation tissue	Minimal	Extensive; fills entire wound bed	Moderate; partial fill before closure
Contraction	Negligible	Significant (myofibroblast-driven)	Moderate
Example	Clean surgical incision (e.g., appendectomy)	Pressure ulcer, large burn, abscess cavity	Contaminated traumatic wound (e.g., bite wound)

🩺 Clinical Note

The distinction between healing by primary and secondary intention has practical implications for nursing care: wounds healing by secondary intention require regular wound bed assessment, moisture management, and debridement of necrotic tissue to support granulation. Wound bed preparation (the TIME framework: Tissue, Infection/Inflammation, Moisture, Edge) guides clinical decision-making for chronic and complex wounds.

SECTION 6

Worked Example: Assessing Wound Healing Progress

The following scenario integrates the cellular, molecular, and temporal principles discussed above. Clinicians and researchers frequently need to assess a wound's stage, predict healing trajectory, and identify factors that may impair repair.

Scenario: Post-Surgical Wound Assessment on Day 5

Step 1 — Identify the Wound Type and ContextA 55-year-old patient with well-controlled type 2 diabetes underwent an abdominal laparotomy. The surgical incision was closed with sutures (healing by primary intention). On post-operative day 5, you examine the wound. The edges are approximated, there is mild erythema and warmth extending ≈1 cm from the incision line, and serosanguineous drainage is minimal.

Wound type: primary intention; Day 5 post-injury

Step 2 — Determine the Expected Healing PhaseReferring to the temporal overlap diagram, day 5 falls at the transition between the late inflammatory phase and the early proliferative phase. We expect the acute inflammatory response (neutrophil-dominant) to be subsiding, with macrophages now orchestrating the shift to proliferative activities. Fibroblast migration into the wound should be underway, and early collagen deposition (type III) is beginning.

Expected phase: late inflammation → early proliferation

Step 3 — Evaluate Clinical Signs Against Expected PhaseThe mild erythema and warmth are consistent with resolving inflammation—vasodilation and increased vascular permeability mediated by histamine, prostaglandins, and bradykinin are still present but should be diminishing. The serosanguineous (clear-pink) drainage is normal and indicates active plasma exudation without significant hemorrhage. If instead we observed purulent (green-yellow) drainage, spreading erythema, increased pain, or fever, these would indicate wound infection—a deviation from normal healing requiring intervention.

Assessment: signs consistent with normal healing trajectory

Step 4 — Consider Complicating FactorsThe patient's type 2 diabetes, even when well-controlled, can impair wound healing via several mechanisms: hyperglycemia reduces neutrophil chemotaxis and phagocytic efficiency, peripheral neuropathy diminishes protective sensation (increasing reinjury risk), and microangiopathy compromises local perfusion and oxygen delivery—a critical substrate for the oxidative burst of phagocytes and for collagen hydroxylation by prolyl hydroxylase (a reaction requiring O₂, Fe²⁺, and vitamin C as cofactors).

Risk factor: diabetes impairs multiple phases; close monitoring warranted

Step 5 — Predict Timeline and OutcomesFor a well-managed primary intention wound without complications, re-epithelialization should be complete within 7–10 days, sutures can be removed around days 7–14 depending on location, and the scar will continue remodeling for up to 2 years. Given the diabetes risk factor, healing may be slightly delayed, and the wound should be monitored for signs of dehiscence (separation of wound edges) particularly if the patient coughs, strains, or has poor nutritional status. The wound's ultimate tensile strength will plateau at approximately 80% of normal skin, regardless of how well it heals.

Predicted: re-epithelialization by days 7–10; full remodeling over 1–2 years; max 80% tensile strength

SECTION 7

Factors Affecting Wound Healing

Wound healing rarely proceeds in an idealized textbook fashion. A wide array of local and systemic factors can accelerate, delay, or entirely stall the repair process. Recognizing these factors is clinically essential because many are modifiable—addressing them is often the most effective intervention available for chronic or stalled wounds.

Local and systemic factors that impair wound healing

Factor	Effect on Healing	Mechanism
Infection	Prolongs inflammation; delays proliferation	Bacterial biofilms sustain neutrophil recruitment, elevate MMPs, consume nutrients and oxygen, and produce tissue-toxic exotoxins.
Hypoxia / Poor perfusion	Impairs collagen synthesis and immune function	Prolyl hydroxylase requires O₂ for collagen cross-linking; neutrophil oxidative burst depends on oxygen; ischemic tissue cannot support angiogenesis.
Diabetes mellitus	Delays all phases; increases infection risk	Hyperglycemia impairs leukocyte function, promotes AGE (advanced glycation end-product) formation, and causes microangiopathy.
Malnutrition (esp. protein, vitamin C, zinc)	Impairs collagen synthesis and immune response	Protein provides amino acid substrates for collagen; vitamin C is a cofactor for prolyl and lysyl hydroxylases; zinc is required for MMP function and cell division.
Corticosteroids	Suppress inflammation and fibroblast activity	Glucocorticoids inhibit phospholipase A₂ (reducing prostaglandin synthesis), suppress cytokine transcription, and decrease fibroblast proliferation and collagen production.
Age (elderly)	Slower but generally adequate healing	Reduced growth factor production, decreased inflammatory response, diminished collagen turnover, and decreased dermal blood flow prolong but do not prevent healing.
Foreign bodies / Debris	Sustains chronic inflammation	Persistent foreign material triggers granulomatous inflammation, prevents wound edge approximation, and provides a nidus for bacterial colonization.

✦ KEY TAKEAWAY

Think of the wound healing process as a construction project that requires raw materials (amino acids, vitamin C, zinc), energy (oxygen and glucose delivered via adequate perfusion), skilled labor (neutrophils, macrophages, fibroblasts), and project management (growth factors and cytokines). If any of these components is missing or disrupted—like a construction site short on supplies, power, workers, or coordination—the project stalls. Clinical wound management therefore focuses on optimizing every one of these inputs: debridement removes obstacles, nutrition supplies raw materials, glycemic control restores worker efficiency, and advanced dressings maintain the optimal microenvironment.

SECTION 8

Repair vs. Regeneration & Advanced Frontiers

A fundamental distinction in tissue biology is between repair and regeneration. Most adult cutaneous wound healing results in repair—the formation of a fibrotic scar that restores structural continuity but lacks the original tissue's hair follicles, sebaceous glands, and organized collagen basket-weave architecture. True regeneration, by contrast, reconstitutes the tissue to its original structure and function, as seen in embryonic/fetal wound healing (which is scarless up to approximately the third trimester) and in certain model organisms like the axolotl. Understanding the molecular differences between these outcomes is a major frontier in biomedical research.

Repair versus regeneration: key molecular and structural differences

Feature	Repair (Adult Wound Healing)	Regeneration (Fetal / Axolotl)
Outcome	Fibrotic scar; loss of adnexal structures	Complete tissue restoration, including appendages
Inflammatory response	Robust; neutrophil and macrophage infiltration	Minimal or absent inflammatory infiltrate
Key growth factor	TGF-β1 and TGF-β2 (pro-fibrotic)	TGF-β3 (anti-fibrotic); higher ratio of IL-10
Collagen pattern	Parallel, dense bundles (scar)	Reticular, basket-weave pattern (normal dermis)
Tensile strength	Reaches ~80% of normal skin	Returns to 100% of normal
Stem cell involvement	Limited contribution from skin stem cell niches	Robust stem/progenitor cell activation; blastema formation

Current research in regenerative medicine aims to shift adult wound healing toward a more regenerative phenotype. Strategies include the application of recombinant TGF-β3, the use of bioengineered skin substitutes (e.g., Integra, Apligraf) that provide a dermal scaffold to guide organized collagen deposition, platelet-rich plasma (PRP) therapy that delivers concentrated growth factors to the wound bed, and stem cell–based approaches that harness the plasticity of mesenchymal stem cells or induced pluripotent stem cells (iPSCs) to regenerate dermal appendages. While none of these strategies has yet achieved true scarless healing in adult humans, they represent the translational frontier where the foundational science of wound healing meets clinical innovation.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

A wound is described as being five days old and dominated by macrophage activity, with early fibroblast migration into the wound bed. Which phase(s) of wound healing is this wound currently in, and what key cytokine shift accounts for the transition?

PROBLEM 2 — BASIC CALCULATION

A circular wound with a diameter of 4 cm is healing by secondary intention. Keratinocytes at the wound margin migrate inward at an average rate of 0.5 mm/day. Assuming uniform migration from all edges and ignoring contraction, approximately how many days would be required for complete re-epithelialization? (Hint: keratinocytes must migrate from the edge to the center.)

PROBLEM 3 — INTERMEDIATE

A patient with scurvy (severe vitamin C deficiency) presents with a wound that has been open for three weeks and shows minimal healing. Explain, at the molecular level, why vitamin C deficiency impairs wound healing, and identify which specific phase(s) are most affected.

PROBLEM 4 — APPLIED

A 68-year-old patient with poorly controlled type 2 diabetes (HbA1c = 9.2%) and peripheral vascular disease presents with a non-healing foot ulcer of eight weeks' duration. The wound bed is covered with a yellowish slough, and there is no visible granulation tissue. Using your knowledge of wound healing phases and impairing factors, explain why this wound has stalled and propose at least three evidence-based interventions that target specific aspects of the healing cascade.

PROBLEM 5 — CRITICAL THINKING

Fetal skin wounds heal without scarring, whereas adult skin wounds produce fibrotic scars. Drawing on the molecular differences between fetal and adult wound healing (specifically TGF-β isoform expression, inflammatory response, and collagen architecture), argue whether it is theoretically possible to achieve scarless healing in adults. What would be the key molecular targets, and what ethical or practical challenges might arise in translating this to clinical use?

SUMMARY

Wound Healing and Skin Repair — Summary

Cutaneous wound healing proceeds through four overlapping phases: hemostasis (platelet plug and fibrin clot formation within minutes), inflammation (neutrophil then macrophage recruitment over hours to days), proliferation (fibroblast-driven granulation tissue formation, keratinocyte re-epithelialization, and angiogenesis over days to weeks), and remodeling (type III to type I collagen replacement and scar maturation over weeks to years). Wounds heal by primary intention (sutured edges, minimal scar), secondary intention (open wound, extensive granulation), or tertiary intention (delayed closure after debridement).

Multiple factors influence healing outcomes, including infection, perfusion and oxygenation, nutritional status (vitamin C, protein, zinc), diabetes, and medications such as corticosteroids. Adult wounds heal by fibrotic repair (scar, ~80% tensile strength), whereas fetal wounds can achieve true regeneration—a difference attributed to the TGF-β isoform profile, degree of inflammatory response, and extracellular matrix composition. Emerging therapies including bioengineered skin substitutes, platelet-rich plasma, and stem cell strategies aim to shift adult healing toward a regenerative outcome.